Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Ann Biol Clin (Paris) ; 71(6): 698-702, 2013.
Article in French | MEDLINE | ID: mdl-24342791

ABSTRACT

Plasma cell leukemia (LP) is a rare hematologic malignancy. Its prognosis is very derogatory. It is defined by the presence in circulating blood of more than 2 G/L plasmocytes or greater than 20% of the total leukocytes. It comes in two forms: secondary plasma cell leukemia complicating multiple myeloma (MM) and primary setting. Its incidence is estimated at 0.9% of patients with acute leukemia and 2-4% of patients with MM. We report, through three observations, the clinical presentation of the plasma cell leukemia, its cytological features, immunophenotypic, physiopathological and therapeutic care.


Subject(s)
Leukemia, Plasma Cell , Aged , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Autografts , Boronic Acids/administration & dosage , Bortezomib , Dexamethasone/administration & dosage , Diabetes Mellitus, Type 2/complications , Diphosphonates/administration & dosage , Hematopoietic Stem Cell Transplantation , Humans , Leukemia, Plasma Cell/complications , Leukemia, Plasma Cell/diagnosis , Leukemia, Plasma Cell/therapy , Male , Middle Aged , Morocco , Pyrazines/administration & dosage , Remission Induction , Thalidomide/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...